Hence, to effectively reactivate APC/CCDH1 E3 ligase activity in cancer via inhibiting negative regulators, activating positive regulators, or both, might hold promise as a potential therapeutic approach to induce the degradation of a group of crucial mitotic regulators that promote oncogenesis. This evidence concerns the gene APC and cancer.